DIAGNOSTIC VALUE OF SEROLOGICAL MARKERS OF RHEUMATOID ARTHRITIS

DIAGNOSTIC VALUE OF SEROLOGICAL MARKERS OF RHEUMATOID ARTHRITIS

Rheumatoid arthritis (RA) is a classic autoimmune disease associated with the production of wide range of autoantibodies, and their detection has diagnostic and prognostic implication. The objective of this study was to estimate the diagnostic value of antibodies against modified citrullinated vimen...

Full description

Bibliographic Details
Main Authors:	Aleksei Leonidovich Maslaynski, S V Lapin, A V Mazing, T V Bulgakova, N M Lazareva, M D Cheshuina, P A Oleinick, E P Ilivanova, A A Totolyan, V I Mazurov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-10-01
Series:	Научно-практическая ревматология
Subjects:	ra33 rheumatoid arthritis immunologic diagnostics autoantibodies rheumatoid factor anti-citrulline antibodies antinuclear factor biomarkers
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1089

Similar Items

Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis
by: Daniela Sieghart, et al.
Published: (2018-04-01)

ANTI-HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1 (ANTI-RA33) ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS
by: P. A. Kuznetsova, et al.
Published: (2017-04-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

Comparism between Anti-RA33, Anti-CCP antibodies and Rheumatoid Factor in the Diagnosis of Rheumatoid Arthritis in Iraqi Patients
by: Ammar H. Al-Ubaidi, et al.
Published: (2013-04-01)

Impact of autoimmune serology test results on RA classification and diagnosis
by: Lieve Van Hoovels, et al.
Published: (2022-01-01)

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis
by: Shawn A. Mahmud, et al.
Published: (2019-01-01)

Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019-04-01)

Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis
by: Dylan T. Bergstedt, et al.
Published: (2022-06-01)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
by: Serena Bugatti, et al.
Published: (2018-12-01)

Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis
by: A.M. Nieto-Colonia, et al.
Published: (2008-03-01)

B cell autoimmunity and bone damage in rheumatoid arthritis
by: S. Bugatti, et al.
Published: (2016-12-01)

Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology
by: Natalia Sherina, et al.
Published: (2017-09-01)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
by: Somayye Norouzi, et al.
Published: (2020-08-01)

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
by: Laura Martinez-Prat, et al.
Published: (2018-06-01)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
by: Ulrike Steffen, et al.
Published: (2019-07-01)

Pitfalls in Diagnosing Seropositive Rheumatoid Arthritis: Haematologic Malignancy Presenting as an Autoimmune Disease
by: Bijit Kumar Kundu, et al.
Published: (2018-03-01)

Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
by: R. E. Costello, et al.
Published: (2021-08-01)

Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach
by: Caterina Bason, et al.
Published: (2021-10-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Study of interleukin 33 in rheumatoid arthritis versus osteoarthritis patients
by: Aliaa M. Abd El-Aziz Farag, et al.
Published: (2017-01-01)

The diagnostic value of the second generation anti-CCP test in rheumatoid arthritis
by: Spasovski Dejan, et al.
Published: (2008-01-01)

Interleukin 33 in premenopausal women with rheumatoid arthritis: Is it related to generalized bone loss?
by: Taghreed F M. Mostafa, et al.
Published: (2020-01-01)

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target
by: Serena Bugatti, et al.
Published: (2021-06-01)

Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects
by: Jiaxi Liu, et al.
Published: (2022-01-01)

IL33 in rheumatoid arthritis: potential contribution to pathogenesis
by: Rafaela Bicalho Viana Macedo, et al.

The spectrum and clinical significance of autoantibodies in rheumatoid arthritis
by: Geraldo Da Rocha Castelar-Pinheiro, et al.
Published: (2015-06-01)

Evaluation of everyday routine changes caused by rheumatoid arthritis (RA). Differences between genders
by: Marta Obrzud, et al.
Published: (2018-04-01)

Evaluation of everyday routine changes caused by rheumatoid arthritis (RA). Differences between genders
by: Marta Obrzud, et al.
Published: (2018-04-01)

Decreased Level of Vitamin D is Associated with Rheumatoid Arthritis Patients from Western Region of Nepal
by: Basant Kumar Tamrakar, et al.
Published: (2018-12-01)

Diagnostic Usefulness of Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin Antibodies in the Diagnosis of Seronegative Rheumatoid Arthritis Patients
by: Bushra Gohar Shah , Asma Saeed , Mohammad Faisal Khan , Hamid Javaid Quershi
Published: (2016-03-01)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
by: V. V. Sokolova, et al.
Published: (2014-07-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by: Marino Paroli, et al.
Published: (2023-10-01)

The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis
by: Daniela Sieghart, et al.
Published: (2023-01-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease
by: Irina A. Pashnina, et al.
Published: (2021-02-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

The reletionship between depression and disability in patient with rheumatoid arthritis in Kerman
by: J Atapour, et al.
Published: (2002-03-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
by: E. A. Golikova, et al.
Published: (2012-05-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)